NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.3 Billion CNY | -18.24% |
| 2022 | 1.75 Billion CNY | 9.59% |
| 2021 | 1.6 Billion CNY | 13.66% |
| 2020 | 1.41 Billion CNY | -2.72% |
| 2019 | 1.45 Billion CNY | 15.22% |
| 2018 | 1.26 Billion CNY | 19.69% |
| 2017 | 1.05 Billion CNY | 7.34% |
| 2016 | 981.2 Million CNY | 3.66% |
| 2015 | 946.55 Million CNY | 5.16% |
| 2014 | 900.13 Million CNY | -0.9% |
| 2013 | 908.29 Million CNY | -16.34% |
| 2012 | 1.08 Billion CNY | -0.81% |
| 2011 | 1.09 Billion CNY | 23.72% |
| 2010 | 884.72 Million CNY | 19.05% |
| 2009 | 743.12 Million CNY | 8.94% |
| 2008 | 682.11 Million CNY | 22.4% |
| 2007 | 557.27 Million CNY | 27.89% |
| 2006 | 435.74 Million CNY | 5.34% |
| 2005 | 413.64 Million CNY | 4.25% |
| 2004 | 396.79 Million CNY | 12.0% |
| 2003 | 354.28 Million CNY | 61.96% |
| 2002 | 218.74 Million CNY | 10.11% |
| 2001 | 198.65 Million CNY | 21.51% |
| 2000 | 163.48 Million CNY | 57.57% |
| 1999 | 103.75 Million CNY | 11.42% |
| 1998 | 93.12 Million CNY | 23.52% |
| 1997 | 75.38 Million CNY | 35.82% |
| 1996 | 55.5 Million CNY | 20.39% |
| 1995 | 46.1 Million CNY | 29.25% |
| 1994 | 35.67 Million CNY | 19.41% |
| 1993 | 29.87 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 430.28 Million CNY | 16.07% |
| 2024 Q2 | 417.35 Million CNY | -3.01% |
| 2024 Q3 | 465.26 Million CNY | 48.15% |
| 2023 Q2 | 422.3 Million CNY | 0.1% |
| 2023 Q4 | 370.7 Million CNY | -17.2% |
| 2023 FY | 1.43 Billion CNY | -18.24% |
| 2023 Q1 | 421.88 Million CNY | -16.98% |
| 2023 Q3 | 447.69 Million CNY | 6.01% |
| 2022 Q1 | 373.22 Million CNY | -17.77% |
| 2022 Q2 | 428.44 Million CNY | 14.8% |
| 2022 Q3 | 449.99 Million CNY | 5.03% |
| 2022 Q4 | 508.19 Million CNY | 12.93% |
| 2022 FY | 1.75 Billion CNY | 9.59% |
| 2021 Q1 | 353.96 Million CNY | 7.68% |
| 2021 FY | 1.6 Billion CNY | 13.66% |
| 2021 Q2 | 385.54 Million CNY | 8.92% |
| 2021 Q3 | 412.46 Million CNY | 6.98% |
| 2021 Q4 | 453.87 Million CNY | 10.04% |
| 2020 Q4 | 328.71 Million CNY | -22.46% |
| 2020 FY | 1.41 Billion CNY | -2.72% |
| 2020 Q1 | 314.49 Million CNY | -23.09% |
| 2020 Q2 | 345.78 Million CNY | 9.95% |
| 2020 Q3 | 423.92 Million CNY | 22.6% |
| 2019 Q1 | 317.66 Million CNY | -24.14% |
| 2019 Q3 | 378.66 Million CNY | 9.07% |
| 2019 FY | 1.45 Billion CNY | 15.22% |
| 2019 Q4 | 408.9 Million CNY | 7.99% |
| 2019 Q2 | 347.17 Million CNY | 9.29% |
| 2018 Q2 | 273.3 Million CNY | -0.2% |
| 2018 Q3 | 294.66 Million CNY | 7.81% |
| 2018 FY | 1.26 Billion CNY | 19.69% |
| 2018 Q4 | 418.72 Million CNY | 42.1% |
| 2018 Q1 | 273.85 Million CNY | -7.69% |
| 2017 Q3 | 268.53 Million CNY | 5.65% |
| 2017 Q1 | 233.83 Million CNY | -9.54% |
| 2017 Q4 | 296.66 Million CNY | 10.48% |
| 2017 Q2 | 254.17 Million CNY | 8.7% |
| 2017 FY | 1.05 Billion CNY | 7.34% |
| 2016 Q3 | 244.64 Million CNY | -2.38% |
| 2016 Q1 | 227.46 Million CNY | -17.82% |
| 2016 FY | 981.2 Million CNY | 3.66% |
| 2016 Q4 | 258.48 Million CNY | 5.66% |
| 2016 Q2 | 250.61 Million CNY | 10.17% |
| 2015 FY | 946.55 Million CNY | 5.16% |
| 2015 Q2 | 228.44 Million CNY | 4.64% |
| 2015 Q4 | 276.8 Million CNY | 24.15% |
| 2015 Q3 | 222.96 Million CNY | -2.4% |
| 2015 Q1 | 218.32 Million CNY | -7.15% |
| 2014 Q3 | 230.69 Million CNY | 3.93% |
| 2014 Q4 | 235.13 Million CNY | 1.92% |
| 2014 FY | 900.13 Million CNY | -0.9% |
| 2014 Q1 | 212.33 Million CNY | -14.97% |
| 2014 Q2 | 221.96 Million CNY | 4.53% |
| 2013 Q4 | 249.7 Million CNY | 11.04% |
| 2013 Q1 | 229.46 Million CNY | -29.39% |
| 2013 FY | 908.29 Million CNY | -16.34% |
| 2013 Q3 | 224.88 Million CNY | 10.11% |
| 2013 Q2 | 204.23 Million CNY | -11.0% |
| 2012 Q1 | 234.22 Million CNY | -35.01% |
| 2012 Q2 | 255.73 Million CNY | 9.18% |
| 2012 Q3 | 270.81 Million CNY | 5.9% |
| 2012 Q4 | 324.98 Million CNY | 20.0% |
| 2012 FY | 1.08 Billion CNY | -0.81% |
| 2011 Q4 | 360.39 Million CNY | 42.68% |
| 2011 Q2 | 233.73 Million CNY | -5.7% |
| 2011 Q1 | 247.86 Million CNY | 1.86% |
| 2011 FY | 1.09 Billion CNY | 23.72% |
| 2011 Q3 | 252.59 Million CNY | 8.07% |
| 2010 Q2 | 205.9 Million CNY | 0.88% |
| 2010 Q1 | 204.1 Million CNY | -1.71% |
| 2010 Q4 | 243.34 Million CNY | 5.18% |
| 2010 FY | 884.72 Million CNY | 19.05% |
| 2010 Q3 | 231.36 Million CNY | 12.37% |
| 2009 Q3 | 183.34 Million CNY | 1.01% |
| 2009 FY | 743.12 Million CNY | 8.94% |
| 2009 Q4 | 207.65 Million CNY | 13.26% |
| 2009 Q1 | 170.62 Million CNY | -14.68% |
| 2009 Q2 | 181.51 Million CNY | 6.38% |
| 2008 Q2 | 161.55 Million CNY | 1.66% |
| 2008 FY | 682.11 Million CNY | 22.4% |
| 2008 Q4 | 199.97 Million CNY | 23.69% |
| 2008 Q3 | 161.67 Million CNY | 0.07% |
| 2008 Q1 | 158.91 Million CNY | -2.41% |
| 2007 Q4 | 162.83 Million CNY | 6.38% |
| 2007 Q1 | 114.22 Million CNY | -13.72% |
| 2007 FY | 557.27 Million CNY | 27.89% |
| 2007 Q2 | 127.15 Million CNY | 11.32% |
| 2007 Q3 | 153.06 Million CNY | 20.37% |
| 2006 Q1 | 97.78 Million CNY | -20.43% |
| 2006 FY | 435.74 Million CNY | 5.34% |
| 2006 Q4 | 132.38 Million CNY | 32.9% |
| 2006 Q3 | 99.61 Million CNY | -5.98% |
| 2006 Q2 | 105.95 Million CNY | 8.35% |
| 2005 Q4 | 122.89 Million CNY | 24.58% |
| 2005 Q1 | 91.66 Million CNY | -31.83% |
| 2005 Q2 | 100.44 Million CNY | 9.58% |
| 2005 Q3 | 98.64 Million CNY | -1.79% |
| 2005 FY | 413.64 Million CNY | 4.25% |
| 2004 Q2 | 92.68 Million CNY | 15.03% |
| 2004 FY | 396.79 Million CNY | 12.0% |
| 2004 Q1 | 80.57 Million CNY | -14.15% |
| 2004 Q3 | 89.06 Million CNY | -3.9% |
| 2004 Q4 | 134.46 Million CNY | 50.97% |
| 2003 FY | 354.28 Million CNY | 61.96% |
| 2003 Q4 | 93.85 Million CNY | 2.48% |
| 2003 Q1 | 65.56 Million CNY | 34.84% |
| 2003 Q2 | 103.28 Million CNY | 57.52% |
| 2003 Q3 | 91.57 Million CNY | -11.33% |
| 2002 Q3 | 61.55 Million CNY | 9.66% |
| 2002 FY | 218.74 Million CNY | 10.11% |
| 2002 Q1 | 52.42 Million CNY | 0.0% |
| 2002 Q2 | 56.13 Million CNY | 7.08% |
| 2002 Q4 | 48.62 Million CNY | -21.01% |
| 2001 FY | 198.65 Million CNY | 21.51% |
| 2000 FY | 163.48 Million CNY | 57.57% |
| 1999 FY | 103.75 Million CNY | 11.42% |
| 1998 FY | 93.12 Million CNY | 23.52% |
| 1997 FY | 75.38 Million CNY | 35.82% |
| 1996 FY | 55.5 Million CNY | 20.39% |
| 1995 FY | 46.1 Million CNY | 29.25% |
| 1994 FY | 35.67 Million CNY | 19.41% |
| 1993 FY | 29.87 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 83.97% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | -76.08% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | 26.773% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | -112.317% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -378.077% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -3497.197% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -181.723% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | -111.687% |